REBECCA KING: Open Payments
NPI 1790344273 · RUSSIAVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$715 in 48 payments from 18 companies in 2025. Trend: 2023 $1,173 · 2024 $1,041 · 2025 $715
Food & beverage: $715
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $172 |
| Lilly USA, LLC | 5 | $85 |
| AstraZeneca Pharmaceuticals LP | 4 | $76 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $67 |
| Axsome Therapeutics, Inc. | 2 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| ABBVIE INC. | 2 | $30 |
| Baxter Healthcare | 1 | $27 |
| Dexcom, Inc. | 1 | $23 |
| Corcept Therapeutics | 1 | $22 |
Products named: Wegovy, MOUNJARO, Kerendia, AIRSUPRA, Auvelity, Ozempic, REXULTI, QULIPTA.
Industry payments across IN — which companies pay providers there.
